Market Overview:
The global 78 kda glucose regulated protein market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of fungal infections, glioma, hemorrhagic fever, and Lassa fever. Additionally, the increasing demand for effective and affordable therapies for these diseases is also contributing to the growth of this market. The 78 kda glucose regulated protein market is segmented on the basis of type into AR-12, HA-15, IT-139, and others. The AR-12 segment is expected to account for the largest share of this market in 2018 owing to its high efficacy in treating various diseases such as fungal infections and glioma. On the basis of application, this market is segmented into fungicidal applications (fungal infections), oncology applications (glioma), hemorrhagic fever prophylaxis (hemorrhagic fever), and Lassa virus prophylaxis (Lassa Fever).
Product Definition:
78 kda Glucose Regulated Protein is a protein that helps regulate the amount of glucose in the blood. It is important for maintaining normal blood sugar levels.
AR-12:
AR-12, also known as 78 kDa glucose regulated protein is a new type of growth factor. It was discovered by accident in the year 2000 while trying to develop an anti-cancer drug. The product name comes from its molecular weight (78kDa) and biological half life (12 minutes). AR-12 has been found to be the most effective growth factor ever discovered for promoting cell proliferation & inhibiting programmed cell death in human cancer cells lines.
HA-15:
HA-15 is a protein that regulates the activity of 78 kDa glucose regulated protein. HA-15 has been identified as an important element in controlling blood glucose levels and its deficiency may lead to type II diabetes.
The normal function of this protein is to ensure that the level of sugar in the bloodstream remains within a normal range by regulating the amount of sugar entering into cells.
Application Insights:
The global 78 kda glucose regulated protein market is segmented on the basis of application into fungal infections, glioma, hemorrhagic fever, Lassa fever and others. The others segment includes dengue infection and viral hepatitis. Fungal infections held the largest share in terms of revenue in 2017 owing to increasing prevalence of HIV-1 across the globe. This has led to increased demand for antiretroviral drugs which are highly effective against HIV-1 but have fewer side effects as compared to other drugs used for treatment such as protease inhibitors and nucleoside reverse transcriptase inhibitors.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period due to increasing incidence of cancer and neurological disorders, which are major applications for regulated proteins. In addition, rising prevalence of fungal infections and emerging as a resultant demand for antifungal drugs will drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to growing healthcare expenditure levels coupled with an increase in awareness regarding diseases prevalent within this region.
Growth Factors:
- Increasing demand for 78 kda Glucose Regulated Protein in the food and beverage industry as a flavor enhancer.
- Rising awareness about the health benefits of 78 kda Glucose Regulated Protein is expected to boost its demand in the dietary supplements market.
- Growing application of 78 kda Glucose Regulated Protein in cosmetics and personal care products is projected to fuel its growth during the forecast period.
- Increasing research and development activities for new applications of 78 kda Glucose Regulated Protein is likely to provide numerous growth opportunities for this market in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
78 kda Glucose Regulated Protein Market Research Report
By Type
AR-12, HA-15, IT-139, Others
By Application
Fungal Infections, Glioma, Hemorrhagic Fever, Lassa Fever, Others
By Companies
Arno Therapeutics, Inc., Intezyne, Inc, Nuevolution AB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global 78 kda Glucose Regulated Protein Market Report Segments:
The global 78 kda Glucose Regulated Protein market is segmented on the basis of:
Types
AR-12, HA-15, IT-139, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fungal Infections, Glioma, Hemorrhagic Fever, Lassa Fever, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Arno Therapeutics, Inc.
- Intezyne, Inc
- Nuevolution AB
Highlights of The 78 kda Glucose Regulated Protein Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- AR-12
- HA-15
- IT-139
- Others
- By Application:
- Fungal Infections
- Glioma
- Hemorrhagic Fever
- Lassa Fever
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 78 kda Glucose Regulated Protein Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
78 kda Glucose Regulated Protein is a protein that is regulated by glucose.
Some of the major companies in the 78 kda glucose regulated protein market are Arno Therapeutics, Inc., Intezyne, Inc, Nuevolution AB.
The 78 kda glucose regulated protein market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 78 kda Glucose Regulated Protein Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 78 kda Glucose Regulated Protein Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 78 kda Glucose Regulated Protein Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 78 kda Glucose Regulated Protein Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 78 kda Glucose Regulated Protein Market Size & Forecast, 2020-2028
4.5.1 78 kda Glucose Regulated Protein Market Size and Y-o-Y Growth
4.5.2 78 kda Glucose Regulated Protein Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 AR-12
5.2.2 HA-15
5.2.3 IT-139
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Fungal Infections
6.2.2 Glioma
6.2.3 Hemorrhagic Fever
6.2.4 Lassa Fever
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 78 kda Glucose Regulated Protein Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 78 kda Glucose Regulated Protein Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 AR-12
9.6.2 HA-15
9.6.3 IT-139
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Fungal Infections
9.10.2 Glioma
9.10.3 Hemorrhagic Fever
9.10.4 Lassa Fever
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 AR-12
10.6.2 HA-15
10.6.3 IT-139
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Fungal Infections
10.10.2 Glioma
10.10.3 Hemorrhagic Fever
10.10.4 Lassa Fever
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 AR-12
11.6.2 HA-15
11.6.3 IT-139
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Fungal Infections
11.10.2 Glioma
11.10.3 Hemorrhagic Fever
11.10.4 Lassa Fever
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 AR-12
12.6.2 HA-15
12.6.3 IT-139
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Fungal Infections
12.10.2 Glioma
12.10.3 Hemorrhagic Fever
12.10.4 Lassa Fever
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 AR-12
13.6.2 HA-15
13.6.3 IT-139
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Fungal Infections
13.10.2 Glioma
13.10.3 Hemorrhagic Fever
13.10.4 Lassa Fever
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 78 kda Glucose Regulated Protein Market: Competitive Dashboard
14.2 Global 78 kda Glucose Regulated Protein Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Arno Therapeutics, Inc.
14.3.2 Intezyne, Inc
14.3.3 Nuevolution AB
